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Abstract
To provide background information about previous findings about the preva-
lence of use, abuse and dependence of various substances (nicotine, alcohol,
prescription and illicit drugs) findings of available epidemiological studies in
Germany from the 1980s and 1990s are summarized and critically evaluated.
Focusing on findings of substance use surveys in adolescents and young adults
the review indicates: (a) a considerable number of large scale questionnaire
surveys in general population samples documenting the frequency of use and
patterns of use of most substances; (b) indications of increasing rates of drug
use particularly in East Germany; (c) high rates of illicit drug use, mainly of
cannabinoids, but also stimulants and hallucinogens, among young age
groups. No data are available from substance use surveys or from clinical epi-
demiological studies allowing the determination of how frequent substance
abuse and substance dependence diagnoses are in the general population or in
adolescents and young adults. Priorities for future research to ameliorate this
unsatisfactory situation are outlined with emphasis on research in adolescents
and young adults.
OOOOOOOOOOOOOOOOOOOOOO
Introduction
The primary objective of epidemiological surveys [1] is
to determine morbidity and to describe morbidity accord-
ing to place, time, and subjects characteristics. This paper
reviews epidemiological studies conducted in the 1980s
and 1990s in Germany with emphasis on studies that also
provide prevalence estimates for adolescents and young
adults. The review covers studies providing estimates of
substance disorders, such as diagnoses of alcohol abuse
and dependence, as well as studies reporting data about
the frequency of use of substances. We included studies
published up to 1995 whose aim was to assess the preva-
lence of substance use in the West or East German popu-
lation. Thus, we excluded the quite considerable number
of cross-sectional and longitudinal studies focusing on
risk factors and developmental patterns obtained in con-
venience or geographically not representative samples or
those not using other key elements of epidemiological
research [2, 3]. Before discussing the available findings in
more detail some critical methodological issues should be
addressed.
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Case Finding Methods
The basic requirement of any epidemiological study
aside from using proper sampling and analysis is a clearly
defined, reliable and valid case definition. Case definition
refers to the way investigators measure the respective
diagnostic features or classes under study. Diagnostic cri-
teria and classes refer to either the use of the International
Classification of Mental Disorders (such as the 10th revi-
sion of ICD-10, WHO 1991 [4]) or the Diagnostic and
Statistical Manual of Mental Disorders (DSM-III, APA
1980 [5] or subsequent revisions, see chap. 3 for details).
Both systems have undergone substantial revisions during
the past decade, with increasing stringency of the respec-
tive explicit diagnostic criteria and diagnostic algorithms
[6]. There are several ways in which a case definition and
especially the assignment of a diagnosis can be made, each
with its own specific advantages and disadvantages. Tra-
ditionally, the gold standard of epidemiological studies is
the use of experienced clinical experts investigating the
total population or representative samples thereof and
assigning diagnoses based on a traditional clinical inter-
view. In assigning diagnoses for the most severe forms of
mental disorders, especially severe psychotic disorders,
this approach evidently seems to be quite reliable and val-
id if need for service or treatment is the key issue to be
studied. However, in the assessment of frequently less
severe disorders, especially anxiety, somatoform, depres-
sive and substance use disorders known to be prevalent in
the general population, clinical expert ratings alone have
been found to be quite unreliable, due to the lack of spe-
cific criteria and the variability in which clinicians make
decisions. Furthermore, these types of epidemiological
studies usually lack a detailed and reliable symptom
assessment. A second, more reliable way in terms of diag-
nosis to study prevalence is the use of diagnostic or symp-
tom checklists. After appropriate training, this approach
ensures that the investigating clinician is reminded and
forced throughout his clinical cross-examination to ad-
dress and code all relevant topic areas. However, for most
disorders this approach has been shown to provide not
sufficiently high reliability estimates on the symptom lev-
el. This disadvantage of checklists can be corrected by
using structured clinical diagnostic interviews that specify
not only the way each symptom is assessed, but also the
way in which the diagnosis is computed at the end of the
interview. Examples for this type of interviews are the
SCAN and the SCID discussed by Lachner et al. [1998,
this issue]. Probably the most reliable and most appro-
priate epidemiological assessment tools for most mental
disorders (except for psychotic and organic mental disor-
ders) are the standardized diagnostic interviews, such as
the CIDI, the DIS or the AUDADIS. These instruments
completely standardize the assessment in terms of ques-
tions, coding and the mostly computerized diagnostic
analysis at the end. After appropriate training the high
degree of standardization also allows the use of this type
of interview by non-clinicians and allows direct compari-
sons across studies, regions, countries and cultures [7].
An alternative, frequently used survey strategy is ques-
tionnaires (see review by Freyberger and Stieglitz [8]).
These questionnaires can either be personally adminis-
tered, mailed or administered by telephone. They can be
quite efficient in providing information relating to var-
ious aspects of morbidity, such as assessing quantity and
frequency, attitudes and behaviors. However, they do not
allow the reliable derivation of clinical diagnoses and syn-
dromes, for example according to the criteria of ICD-10
or DSM-IV.
Epidemiological Studies on Substance Use and Abuse
in Germany
Epidemiology research on substance use and disorders
in Germany over the past two decades was primarily con-
ducted by using questionnaire approaches assessing the
frequency of substance use, its association with sociode-
mographic characteristics along with information about
availability, patterns of use, motivations and attitudes.
The primary aim of these descriptive representative sur-
veys was to describe the frequency of drug and alcohol use
and its determinants and has been expanded in the last
few years into more comprehensive assessments covering
medically prescribed drugs and health status variables as
well as risks and complications [9]. In contrast to the wide
variety of available questionnaire studies, only very few
studies with significant limitations have been conducted
by clinical experts or standardized diagnostic instruments
to assess the prevalence of substance use disorders.
Findings from Questionnaire Surveys in General
Population Samples Aged 18–59 Years
Numerous studies providing questionnaire data of the
use of substances in general population samples are avail-
able, many of which are only available in the form of
reports such as those by survey institutes, federal or state
agencies (e.g. Infratest [10–13]; 1982, 1986, 1990, 1993,
Institut für Jugendforschung, see Reuband [9]; Bundes-
ministerium für Gesundheit BMG [14–16]), but not as
peer-reviewed publications. As direct comparisons be-
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Table 1. Methods and sample sizes of the BMG studies on sub-
stance use
Year Methods Region Age
range
Sample
size
Completion
rate
1986 mailed West 12–29 5,501 63.7
1990 mailed West
East
12–39 19,208
2,424
63.8
65.4
1992 mailed East 12–39 4,455 54.3
1994 telephone West
East
18–59 2,027
473
78.3
66.3
1995 mailed West
East
18–59 6,292
1,541
64.8
66.0
Table 2. Prevalence of use of illicit substances in East and West
Germany [16]
West, %
total men women
East, %
total men women
Total illicit drugs 14.6 19.3 9.9 4.0 6.0 2.0
Cannabinoids 13.9 18.4 9.4 3.6 5.8 1.4
Other illicit drugs 5.4 7.5 3.4 1.6 2.1 1.1
By type of illicit drug
Cannabinoids 13.9 18.4 9.4 3.6 5.8 1.4
Stimulants 2.8 3.9 1.7 0.7 0.6 0.9
Ecstasy 1.6 2.4 0.7 0.7 1.3 0.1
LSD 2.1 2.8 1.2 0.3 0.4 0.2
Heroin 0.6 0.8 0.4 0.1 0.1 0.1
Methadon 0.3 0.4 0.1 0.0 0.0 0.0
Other opiates 1.2 1.7 0.7 0.2 0.4 0.0
Cocaine 2.2 3.2 1.2 0.2 0.3 0.1
Crack 0.2 0.4 0.1 0.1 0.1 0.0
Inhalants 0.9 1.2 0.6 0.4 0.7 0.1
Any illicit drug by age group1
18–20 24.8 14.2
21–24 27.4 25.1
25–29 25.5 4.5
30–39 17.2 1.4
40–49 10.7 1.2
50–59 2.5 0.3
1 Data only available for the total population.
Table 3. Comparison of lifetime and 12-month use rates 1990 to
1995 [16]
West, %
1990 1994 1995
East, %
1990 1994 1995
Lifetime
Cannabinoids 16.7 18.9 21.0 1.0 4.3 6.4
Total illicit drugs 18.4 19.6 21.8 1.1 5.1 7.1
12 months
Cannabinoids 4.9 4.4 8.8 0.7 1.5 3.5
Total illicit drugs 5.1 4.5 9.5 0.8 1.5 3.5
tween the studies are difficult because of the use of differ-
ent instruments, we will discuss in more detail the find-
ings of the largest available set of data, namely the federal
commissioned surveys, focusing for the purpose of this
supplement on the 1995 data [16]. This study is the fifth
in a series of studies commissioned by the government
and conducted by various survey institutes (Infratest,
Institut für Therapieforschung) since 1986 (table 1).
Illicit Drugs
In 1995, assessed by a mailed questionnaire, 19.3% of
the male Western and 6% of the male Eastern German
population aged 18–59 years reported that they had used
illicit drugs at least once in their life. This suggests that
illicit drug use is still considerably lower in East Germany.
For women the rates were 9.9% (west) and 2% (east). As
table 2 suggests, cannabinoids were found to be the most
frequent type of substance used (lifetime use prevalence:
West 13.9%, East 3.6%), followed by stimulating sub-
stances (cocaine and amphetamines) and hallucinogens.
The prevalence of use of opiates is quite low with esti-
mates of 0.3–1.2% in the Western and 0.1–0.2% in East-
ern states. Rates for men are consistently and markedly
higher than for women. Furthermore, younger age groups
(18–29) report the use of illicit substances almost twice as
frequently as subjects aged 30–59 years in both West and
East Germany.
The 12-month rates of 1995 (percentage of users indi-
cating the use of a substance within the past 12 months)
are about one third lower in East compared to West Ger-
many, the former also having about half the number of the
lifetime rates. In almost 90% of all lifetime users drug use
was limited to hashish/marijuana. A more detailed inqui-
ry into patterns of use also suggest that there is consider-
able polydrug use, especially in those reporting the use of
hard drugs and in those reporting regular use. In almost
two thirds of lifetime users the substance was consumed
only occasionally.
The comparison of lifetime and 12-month use rates for
all illicit drugs and for cannabis in table 3 for 18- to 39-
year-olds reveals that there is a slight and continuous
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Table 4. Current average amount of
alcohol used in grams of absolute ethanol
(averaged over 30 days by quantity and
frequency and alcohol content) [16]
Pure alcohol/day Total
West East
Age groups (West)
18–20 21–24 25–29 30–39 40–49 50–59
Men
0 16.3 12.8 31.1 18.9 14.3 12.2 16.4 17.2
1–10 31.5 23.6 40.7 34.5 33.3 34.6 27.8 27.3
11–20 19.3 20.1 6.4 19.0 22.0 19.2 20.3 19.9
21–40 17.8 23.1 11.4 14.8 17.1 18.0 20.0 18.7
41–60 7.7 11.3 5.9 4.7 7.6 8.5 7.5 8.7
61c 7.4 9.2 4.5 8.1 5.7 7.4 8.0 8.2
Women
0 30.0 20.8 38.1 32.5 30.4 26.5 29.6 30.9
1–10 49.2 53.9 48.8 51.6 49.8 54.7 44.5 46.8
11–20 10.8 14.7 4.1 10.3 9.7 9.4 13.3 12.4
21–40 6.5 7.2 6.2 4.0 8.0 6.0 8.0 5.8
41–60 2.1 2.1 2.3 1.6 1.3 1.9 3.1 2.1
61c 1.4 1.3 0.5 0.0 0.8 1.5 1.5 2.0
Harmful use
Men (140 g/day) 15.1 20.5 10.4 12.8 13.3 15.9 15.6 16.8
Women (120 g/day) 10.0 10.6 9.0 5.6 10.1 9.4 12.6 9.9
increase in illicit rates in West Germany with a consider-
able increase in East Germany. This comparison should
be made cautiously, however, because of the varying
methodologies used (telephone versus mailed question-
naire, different questions and age groups, see Schumann
and Kraus [17], the differing response rates as well as the
obviously different sampling schemes and weighting pro-
cedures.
Although these surveys offer additional data about the
motivations for starting, the discontinuation as well as the
consequences of drug use and drug availability, these sur-
vey data unfortunately do not allow indications of preva-
lence estimates for abuse and dependence diagnoses ac-
cording to international diagnostic classification systems.
Alcohol
The 1995 BMG survey offers detailed information
about consumption patterns as well as estimates for harm-
ful use of alcohol defined as an intake of at least 40 g pure
alcohol for men and 20 g pure alcohol per day for women.
Table 4 summarizes total rates (by gender) in East and
West Germany as well as by age group for West Germany,
for the amount of alcohol in terms of gram of pure alcohol
consumed. These data are based on quantity and frequen-
cy descriptions of various types of alcohol over the past 30
days for which the absolute alcohol content is roughly
known. The total over 30 days was averaged to represent
daily consumption of gram absolute ethanol. Beer is by far
the most frequent beverage consumed, followed by wine
and spirits.
Table 4 indicates a considerably lower alcohol con-
sumption for women than for men, and slightly higher
rates in East Germany. The prevalence of abstainers in
West Germany (men: 16.3%; women: 30%) is higher than
in East Germany (men: 12.8%; women 20.8%). Abstainer
rates are highest among 18- to 20-year-olds and decrease
overall, with some fluctuations, with increasing age.
Harmful use of alcohol in terms of the average daily
amount of alcohol consumed during the past month was
15.1% for men and 10.0% for women in West Germany.
Rates for harmful use increased by age group from 10.4%
(9.0% for women) among 18- to 20-year-olds to 16.8%
(women: 9.9%) among 50- to 59-year-olds in West Ger-
many.
Psychotropic Medicines
In 1994, 12.2% of the sample reported the intake of
psychotropic medicines, either prescribed or not pre-
scribed (e.g. sedatives, analgesics, sleeping pills, stimu-
lants, appetite suppressants) with a frequency of at least
once a week in the last month. The rates were similar for
West (12.5%) and East Germany (11.2%). Women re-
ported higher use rates than men. Consumption of psy-
chotropic medicines increased with age, the highest rates
being found in the 40-year-olds and over. In 1995, 16%
(women: 19.3; men: 12.8%) of the respondents had con-
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Fig. 1. One-month prevalence rates (%) of use of psychotropic
medicines among adults in 1994 and 1995 [15, 16].
Fig. 2. Prevalence rates (%) of nicotine use (current smokers)
among adults in 1994 and 1995 [15, 16].
sumed psychotropic medicines at least once per week dur-
ing the last month. As in the 1994 survey, women (19.3
and 19.4%) had higher rates of psychotropic medicine use
than men (13.0 and 11.9%) (fig. 1). It is noteworthy, how-
ever, that among respondents aged 18–20 years, 11.4% of
men and 10.7% of women in West Germany reported reg-
ular use of psychotropic medications with a similar fre-
quency in the age group 21–24 years; however, a marked
sex difference was apparent (men: 6.2%; women: 14.8%)
that continued to be present among all higher age groups.
No data are available about clinically significant abuse
and dependence syndromes.
Tobacco
In 1995, 35.8% of respondents in West and 36.9% in
East Germany described themselves as being smokers,
25.9% (West) and 23.1% (East) indicated having been
smokers in the past and 38.3% (39.9% East) described
themselves as having never smoked regularly. Figure 2
indicates that the 1995 current smoker prevalence rates
are slightly higher than those for 1994, with a continuing
sex difference.
Substance Use Findings from Questionnaire
Surveys among Adolescents and Young Adults
For the purpose of this supplement it is also of interest
to briefly summarize findings for substance use specifical-
ly among 14- to 24-year-olds. To study the use of sub-
stances in adolescents and young adults, the Federal Cen-
ter for Health Education (Bundeszentrale für gesundheit-
liche Aufklärung BZgA1994 [18]) conducted a representa-
tive survey in 3,000 subjects in 1994. Table 5 briefly sum-
marizes the core findings [18] that are by and large in
agreement with the findings of the survey cited above.
58% of the respondents reported drinking beer, wine or
spirits at least once during the past week. Consumption
rates for men were considerably higher than those for
women. It seems noteworthy, that in East Germany spir-
its and mixed drinks are more frequent than in West Ger-
many. 26% of 14- to 24-year-olds indicated that they
smoked regularly. The rates were slightly higher in West
Germany (27 vs. 23%) and men were more frequently
(29%) regular smokers than were women (23%). Eighteen
percent of those aged 14–24 years reported the use of illi-
cit drugs at least once in their lifetime. Women were less
likely than men (12 vs. 23%) to have used illicit drugs. In
West Germany the prevalence of lifetime use was more
than three times higher (21%) than rates for East Germa-
ny (6%), with cannabinoids being by far the most fre-
quently used type of illicit drug.
Results of Psychiatric Epidemiological Studies
Compared to other countries, in Germany only very
few psychiatric epidemiological data from general popu-
lation samples are available for the estimation of the
prevalence of abuse of, and dependence on substances.
Table 6 shows that there have been four studies, all using
different instruments (except the Upper Bavarian Stud-
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Table 5. Prevalence of substance use
among 14- to 25-year-olds in Germany [18] Proportion (%) of respondents reporting
total West Germany
total men women
East Germany
total men women
Use of alcohol at least once a week
Beer 31 32 51 12 28 48 5
Wine 10 10 10 11 10 7 14
Spirituous liquors 7 6 9 3 10 17 2
Alcoholic mixed drinks 10 8 11 6 15 19 10
Current smokers 26 27 29 24 23 28 17
Lifetime use of illicit drugs 18 21 27 14 6 10 2
Table 6. Epidemiological studies of prevalence of mental disorders including substance use disorders (SUD) in
Germany
Study Diagnosis Sample size
age group
Time frame Prevalence of SUD, %
alcohol drug any SUD
Dilling et al. [19] ICD-8 n = 1,536/15+ 1 week 3.5 0.3 3.8
Traunstein (Bavaria) clinicians aged 15+
1975–1978
Fichter et al. [20] ICD-8 n = 1,385/20+ 1 week 4.0
Traunstein follow-up DSM-III n = 1,495/20+ 5 years 5.9 1.4 7.3
1980–1983 clinicians aged 20+
Tress and Schepank [21] ICD-8 n = 600 1 week 1.3 0.2 1.5
Mannheim 1979–1985 clinicians aged 25–45
Wittchen and von Zerssen [22] DSM-III n = 1,366 6 months 1.2 0.6 1.6
West Germany clinicians aged 25–64 lifetime 13.0 1.8 13.5
1981 DIS (interview)
ies), designs, samples and with an overall quite modest
sample size. Dilling et al. [19] studied the frequency of
mental disorders in a small town rural region of Upper
Bavaria. The point prevalence of dependence for alcohol
and drugs according to ICD-8 was estimated to be 3.8%
in this region at the time of the study. 1.9% were diag-
nosed with mild dependence and 1.8% as having severe
dependence [23]. Fichter et al. [20] in a follow-up investi-
gation of the same sample 5 years later estimated a higher
prevalence of an overall 4.0% according to ICD-8, 75% of
which already had alcoholism or drug dependence in the
initial wave. The percentage of chronic cases with alco-
holism or drug dependence was 40.6%. 43.8% were rated
as completely or partially remitted. According to DSM-
III criteria the 5-year prevalence estimate of alcohol
dependence was 0.9%, and 5.0% for alcohol abuse. Drug
abuse and dependence was estimated with a prevalence
rate of 1.4%.
In another survey, Tress and Schepank [21] reported
similarly low prevalence rates of substance disorders with
1.5% having definite severe and 2.5% mild dependence
symptoms. Another study in Mannheim revealed that
6.4% of all psychiatric cases in general practices were
diagnosed by the interviewer to have alcoholism or drug
dependence according to ICD-8 [24].
Considerably higher lifetime estimates of 13% for alco-
hol dependence and 1.8% for drug dependence were
found by Wittchen and von Zerssen [22] in the Munich
Follow-up Study, using standardized diagnostic inter-
views according to DSM-III criteria in a representative
sample of 1,366 respondents of West Germany, aged 25–
64 years. The 6-month rates, however, were considerably
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Table 7. Prevalence studies of substance use disorders (SUD) with standardized interviews according to opera-
tionalized diagnoses in various countries
Study, year Country/site Sample size Time frame Prevalence, %
any
SUD
alcohol
SUD
drug
SUD
Eca, 1980–1984 5 sites in USA 18,572 1 month 3.8 2.8 1.3
Regier et al. [27] 6 months 6.1 4.8 2.0
Anthony and Helzer [28]
Helzer et al. [29]
lifetime 16.7 13.5 6.2
New Haven 1 month 3.2 1.1
1 year 6.1 2.6
lifetime 15.0 11.3 5.9
Baltimore 1 month 4.7 1.4
1 year 7.7 2.9
lifetime 17.0 15.2 5.8
St. Louis 1 month 2.5 1.5
1 year 7.5 2.2
lifetime 18.1 15.9 5.6
Durham 1 month 2.7 0.6
1 year 5.1 1.6
lifetime 12.8 10.7 3.8
Los Angeles 1 month 3.7 1.7
1 year 7.0 2.9
lifetime 18.5 15.0 7.6
NCS, 1990–1992 USA 8,098 1 year 11.3 9.7 3.6
Kessler et al. [30] lifetime 26.6 23.5 11.9
Puerto Rico, 1984 Puerto Rico 1,551 6 months 4.9 2.7
Canino et al. [31] lifetime 12.6 7.0
Canada, 1983–1986 Edmonton 3,258 point 3.9 3.4 1.1
Bland et al. [32, 33] 6 months 6.3 5.4 1.7
1 year 9.1 7.9 2.6
lifetime 20.6 18.0 6.9
Korea Seoul 3,134 lifetime 31.8 21.7 0.9
Lee et al. [34, 35]
New Zealand, 1986 Christchurch 1,498 point 6.9 6.5 0.8
Wells et al. [36] 6 months 9.1 8.3 1.5
1 year 10.5 9.3 2.3
lifetime 21.0 18.9 5.7
Taiwan, 1982–1985 Taipei 5,005 1 year 19.2 0.6
Hwu et al. [37] lifetime 48.5 1.0
lower with 1.2% for alcohol and 0.6% for drug depen-
dence. As one potential reason for these lower 6-month
estimates the authors suggested that subjects with sub-
stance dependence seemed to be more likely to admit to
past than to current symptoms and concluded, based on a
case-by-case review, that most of the cases with a lifetime
diagnosis could be regarded, at best, as partially remitted
[25].
Dilling et al. [19] in the Traunstein Study also assessed
patterns of use of psychotropic medicines. They found
that 8.1% of all respondents had taken at least one psycho-
tropic medicine during the 7 days prior to the interview
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(irrespective of whether prescribed or not). As expected,
the highest consumption rate was found among those suf-
fering from psychiatric illness. Fichter et al. [20] reported
1-month rates of psychotropic medication use and esti-
mated that 18.1% had taken psychotropic medicines dur-
ing the previous 2 weeks. This estimate, however, does
not include hypnotics and sedatives estimated with a fre-
quency of 4.8%.
Studies on Substance Use Disorders in Other
Countries
Several large-scale epidemiological studies have been
conducted to assess the lifetime and 12-month prevalence
of substance use disorders in several countries on the basis
of DSM-III diagnostic criteria and by using standardized
diagnostic interviews, such as the Diagnostic Interview
Schedule (DIS) [26]. Thus, results from these studies can
be compared across regions. Moreover, these studies pro-
vide detailed information about specific types, symptoms
and the age of onset of clinically significant substance use
disorders. As shown in table 7, the lifetime prevalence of
substance use disorders has been estimated with rates
ranging between 16.7 and 31.8%. Highest rates have been
found in the Korean Study and in the US National
Comorbidity Survey (NCS), where approximately 1 in
every 4 respondents reported a lifetime history of one sub-
stance use disorder (not including nicotine dependence).
However, the NCS results are based on the newer DSM-
III-R criteria and the use of the CIDI as the diagnostic
instrument, whereas the results of all other studies are
based on the DSM-III and the DIS as the diagnostic pro-
cedure. As can be seen in table 7, lifetime estimates for
alcohol disorders range from 12.6 to 48.5%. Current rates
as defined as 6- or 12-month diagnoses ranged from 4.8 to
19.2%. Similarly, rates of drug use disorders were also
considerably high with lifetime estimates ranging from
0.9 to 11.9%.
Thus, in all countries prevalence estimates for sub-
stance use disorders are not only considerably higher than
those found in Germany, but overall they were also
among the most frequent types of mental disorders [38,
39]. It can be assumed that these tremendous country dif-
ferences are due to the very different case finding methods
as well as the diagnostic classification system used (DSM-
III compared to ICD-8).
Discussion
Our review clearly shows that there are a substantial
number of studies conducted over the past decade in gen-
eral population samples demonstrating that the use of
nicotine, alcohol as well as licit and illicit drugs is wide-
spread. Furthermore, these studies have not only identi-
fied age-group- and gender-specific correlates of use for
most types of substances, but have also provided consid-
erable evidence for differences between regions, specifi-
cally between East and West Germany, as well as changes
over time [40–42].
Although one might still argue about the methodologi-
cal quality of these studies in terms of completion rates,
consistency of instrument used, the poorly documented
psychometric properties of assessment tools as well as the
sampling methods and the lack of sophistication in the
analyses, these studies, given their sample size and the rel-
ative consistency over time, nevertheless provide impor-
tant and essential data about how widespread psychotrop-
ic substance use is in Germany.
Use of illicit drugs is particularly prevalent among ado-
lescents and young adults with some indications that use
rates are rising – slightly in West Germany and more strong-
ly in East Germany [3]. Although these substance use stud-
ies additionally provide a wide variety of information con-
cerning motivation patterns, consequences and associated
risk factors, they do not allow any reasonable estimate
about how frequently these substances are abused, how
many subjects have developed a dependence syndrome
and, ultimately, which number of cases have developed a
clinically significant abuse or dependence disorder.
These essential questions can also not reliably be
answered by consulting the very few psychiatric epidemi-
ological studies available, assessing the prevalence of
mental disorders including substance abuse and depen-
dence. All these studies were conducted in the 1980s and
thus tell us nothing about the 1990s. All were too small to
provide sufficiently stable prevalence estimates for sub-
stance use disorders especially for young adults due to
very small base rates, and only one has reported preva-
lence data for substance use disorders as defined in one of
the more recent diagnostic classification systems such as
DSM or the ICD-10. Taking methodologically sound
studies in other countries [38] as a yardstick, the fairly low
estimates of these psychiatric epidemiological studies also
raise serious doubts about the credibility of prevalence
rates for substance use disorders reported. Apart from the
Munich Follow-up Study [22], the German prevalence
studies have estimated rates for alcohol and drug use dis-
U59:ZEUAR128XA SIBY
16 Eur Addict Res 1998;4:8–17 Perkonigg/Lieb/Wittchen
orders that are only a fraction of those estimated for most
other western industrialized countries. This calls into
question the sensitivity with which these studies identi-
fied substance use disorders.
As the basis of descriptive and causal epidemiological
studies is to measure morbidity by using sufficiently
detailed and reliable diagnostic assessment tools, this
unsatisfactory situation clearly signals the urgent need for
large scale epidemiological studies in Germany. Such
studies should focus, in addition to assessing quantity and
frequency of substance use, specifically on estimating the
prevalence of substance specific symptoms of abuse and
dependence in various subgroups of the population, their
age of onset, associated vulnerability and risk factors as
well as psychosocial and medical consequences of sub-
stance use disorders. Other important issues resulting
from clinical observation as well as the substance use sur-
veys [43] is the examination of the interrelationship of
use, abuse and dependence of various types of psycho-
tropic substances, as well as their relationship to other
mental disorders (comorbidity).
The literature review also revealed a deficit of studies
investigating typical developmental patterns from use to
abuse and to dependence especially in adolescents and
young adults. This lack is obviously not due to the diffi-
culties of longitudinal studies in adolescence in general,
because there are substantial numbers of such studies [42,
44]. Rather, the deficit stems from not using instruments
allowing the assessment of clearly specified diagnostic cri-
teria for abuse and dependence. It is frequently assumed
that many adolescents show only transient patterns of
drug abuse and stop using drugs spontaneously without
any formal intervention. However, no data from retro-
spective or prospective longitudinal studies in representa-
tive samples of the population are available investigating
this key issue in more detail in order to determine those
factors increasing the likelihood for transitions from first
use to regular use as well as from use to manifest forms of
substance use disorders. Such substance-specific informa-
tion is essential for early prevention of substance use dis-
orders.
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